The proportions of low and high GGH expression cases differed significantly according to the clinical stage, histological grade, primary therapy outcome, race/ethnicity, surgical approach, and TP53 mutation status, but not by residual tumor percentage class, histological type, diabetes status, menopause status, hormone therapy treatment, or radiotherapy treatment. Here, TP53 is linked to neoplasm.